Tratamento atual da insuficiência cardíaca descompensada / Current insights into the modern treatment of decompensated heart failure / Current insights into the modern treatment of decompensated heart failure
Arq. bras. cardiol
;
87(3): 369-377, set. 2006. ilus, tab
Article
in Portuguese, English
| LILACS
| ID: lil-436201
RESUMO
O tratamento de ICD representa um desafio até mesmo para o médico experiente. Os avanços alcançados nas pesquisas propiciaram novas opções de tratamento que estão ajudando a mudar paradigmas. As evidências indicam que novos fármacos como a levosimendana e nesiritida representarão importantes alternativas ou complementos ao tratamento com medicamentos inotrópicos tradicionais, como a dobutamina. O médico responsável pelo tratamento desses pacientes deve aprender a usar as melhores evidências disponíveis para individualizar o tratamento com segurança e eficácia.
ABSTRACT
Treatment of DHF is a challenge even for the experienced physician. Advances in research have brought new treatment options that are helping change paradigms. The available evidence suggests that new drugs like levosimendan and nesiritide will assume relevant positions as alternatives or complements to treatment with traditional inotropic drugs like dobutamine. The physician responsible for treating these patients should learn how to use the best available evidence, in order to tailor treatment with safety and efficacy.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Heart Failure
/
Hemodynamics
Limits:
Humans
Language:
English
/
Portuguese
Journal:
Arq. bras. cardiol
Journal subject:
Cardiology
Year:
2006
Type:
Article
Affiliation country:
Brazil
/
Switzerland
Institution/Affiliation country:
Hospital Espanhol/BR
/
Hospital Universitário de Zürich/CH
Similar
MEDLINE
...
LILACS
LIS